POSTER PRESENTATIONS
Arthritis
Cancer
Cardiovascular Disease
Diabetes
Infectious Diseases
Mental
Health
Respiratory Disorders
Other Diseases and Disorders
QUALITY
OF LIFE
& UTILITY
STUDIES
Arthritis and Neurological Diseases
Cancer
Cardiovascular Disease
Diabetes
Mental
Health
Respiratory Disorders
Other Diseases and Disorders
Methods
METHODS AND
CONCEPT PAPERS
CLINICAL OUTCOMES STUDIES
PCOS1:
COMMUNITY-BASED OUTCOMES RESEARCH INITIATIVE FOR CHRONIC RENAL DISEASES
Sasahara E1, Iida E1, Tajima Y1, Terajima T1, Ogawa
M2, Yoshida H3, Irie Y3, Yamagata S1, Satoh N1, Ueda S1, 1Chiba University
Graduate School of Pharmaceutical Sciences, Chiba-shi, Chiba, Japan;
2Chiba University Graduate School of Medicine, Chiba-shi, Chiba, Japan;
3Sanai Memorial Hospital, Chiba-shi, Chiba, Japan
PCOS5:
EVIDENCE ON THE RELATIVE EFFECTIVENESS OF
OLANZAPINE AND RISPERIDONE OVER TIME
Davey P, FitzGerald P, Birinyi-Strachan L, M-TAG Pty Ltd, Chatswood, NSW,
Australia
PCOS10:
EVALUATION OF CLOPIDOGREL USE IN MEDICAL
PATIENTS OF A GENERAL TEACHING HOSPITAL
Lee VW, Lau CC, Lau CS, Mo CL, Chan TY, The Chinese University of Hong
Kong, Shatin, Hong Kong
COST STUDIES
COST STUDIES - CARDIOVASCULAR DISEASE
PCSCD1:
COST-EFFECTIVENESS OF STATINS AFTER
REVISION OF NCEP ATPIII: COMPARISON BETWEEN ATORVASTATIN AND SIMVASTATIN
Cheng CW, You JH, The Chinese University of Hong Kong, Hong Kong, China
PCSCD3:
COST-MINIMIZATION ANALYSIS IN
HYPERTENSION WITH CORONARY ARTERY DISEASE BASED ON JAPAN MULTICENTER
INVESTIGATION FOR CARDIOVASCULAR DISEASE DATA: NIFEDIPINE RETARD VERSUS
ACE-INHIBITOR
Fujikawa K1, Yui Y2, Kawai C2, Jmic B3, 1Bayer Yakuhin Ltd, Osaka, Osaka,
Japan; 2Kyoto University Hospital, Kyoto, Kyoto, Japan; 3JMIC-B
Investigators, Kyoto, Kyoto, Japan
COST STUDIES -
INFECTIOUS DISEASES
PCSID10:
A COST ANALYSIS OF CHRONIC HEPATITIS B
INFECTION & ITS ASSOCIATED COMPLICATIONS IN SINGAPORE
Ong SC, Lim SG, Yeoh KG, Li SC, National University of Singapore,
Singapore, Singapore
COST STUDIES -
MENTAL HEALTH
COST STUDIES -
RESPIRATORY DISORDERS
COST STUDIES - OTHER DISEASES AND DISORDERS
QUALITY OF LIFE & UTILITY STUDIES
QUALITY OF LIFE & UTILITY STUDIES -
ARTHRITIS AND NEUROLOGICAL DISEASES
QUALITY OF LIFE & UTILITY STUDIES - CANCER
QUALITY OF LIFE STUDIES - CARDIOVASCULAR DISEASE
QUALITY OF LIFE STUDIES - DIABETES
QUALITY OF LIFE & UTILITY STUDIES - MENTAL
HEALTH
QUALITY OF LIFE & UTILITY STUDIES -
RESPIRATORY DISORDERS
QUALITY OF LIFE STUDIES - OTHER DISEASES
AND DISORDERS
QUALITY OF LIFE STUDIES - METHODS
HEALTHCARE POLICY STUDIES
PHP8:
FACTORS CONSIDERED IN PHARMACEUTICAL
REIMBURSEMENT IN AUSTRALIA: A ROLE FOR THE RULE OF RESCUE?
PHP8(2)
Wonder M, De Abreu Lourenco R, Novartis Pharmaceuticals Australia Pty Ltd,
North Ryde, NSW, Australia
PHP9:
MANDATORY INCLUSION OF PHARMACOECONOMICS IN
DRUG FUNDING - LESSONS FROM THE AUSTRALIAN APPROACH 1993 – 2003
Davey P, Lees M, Makino K, M-TAG Pty Ltd, Chatswood, NSW, Australia
METHODS AND CONCEPT PAPERS
1st
Asia-Pacific Conference Main Page